Deferred Tax Assets, Valuation Allowance of Silexion Therapeutics Corp from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Silexion Therapeutics Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • Silexion Therapeutics Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $6,899,000, a 25% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Silexion Therapeutics Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $6,899,000 +$1,392,000 +25% 31 Dec 2024 8-K 20 Aug 2025
Q4 2023 $5,507,000 +$922,000 +20% 31 Dec 2023 8-K 20 Aug 2025
Q4 2022 $4,585,000 31 Dec 2022 8-K 20 Aug 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.